Rajan Suja S, Suryavanshi Manasi S, Karanth Siddharth, Lairson David R
1 Department of Management, Policy, and Community Health, School of Public Health, The University of Texas Health Science Center , Houston, Texas.
2 Department of Pharmacy Administration, The University of Mississippi School of Pharmacy , Jackson, Mississippi.
Popul Health Manag. 2017 Apr;20(2):155-164. doi: 10.1089/pop.2015.0180. Epub 2016 Aug 26.
Regular screening is considered the most effective method to reduce the mortality and morbidity associated with breast cancer. Nevertheless, contradictory evidence about screening mammograms has led to periodic changes and considerable variations among different screening guidelines. This study is the first to examine the immediate impact of the 2009 US Preventive Services Task Force (USPSTF) guideline modification on physician recommendation of mammograms. The study included visits by women aged 40 years and older without prior breast cancer from the National Ambulatory and Medical Care Survey 2008-2010. Bivariate and multiple logistic regressions were used to determine the factors associated with mammography recommendation. Approximately 29,395 visits were included and mammography was recommended during 1350 visits; 50-64-year-old women had 72% higher odds, and 65-74-year-old women had twice the odds of getting a mammogram recommendation compared with 40-49-year-old women in 2009. However, there was no difference in recommendation by age groups in 2008 and 2010. Obstetricians and gynecologists did not modify their recommendation behavior in 2009, unlike all other specialists who reduced their recommendation for 40-49-year-old women in 2009. Other characteristics associated with mammogram recommendations were certain patient comorbidities, physician specialty and primary care physician status, health maintenance organization status of the clinic, and certain visit characteristics. This study demonstrated a temporary effect of the USPSTF screening guideline change on mammogram recommendation. However, in light of conflicting recommendations by different guidelines, the physicians erred toward the more rigorous guidelines and did not permanently reduce their mammogram recommendation for women aged 40-49 years.
定期筛查被认为是降低乳腺癌相关死亡率和发病率的最有效方法。然而,关于乳腺钼靶筛查的相互矛盾的证据导致了不同筛查指南的定期变化和显著差异。本研究首次考察了2009年美国预防服务工作组(USPSTF)指南修订对医生推荐乳腺钼靶检查的即时影响。该研究纳入了2008 - 2010年美国国家门诊医疗调查中年龄在40岁及以上且无乳腺癌病史的女性就诊病例。采用双变量和多因素逻辑回归来确定与乳腺钼靶检查推荐相关的因素。共纳入约29395次就诊病例,其中1350次就诊被推荐进行乳腺钼靶检查;与2009年40 - 49岁女性相比,50 - 64岁女性接受乳腺钼靶检查推荐的几率高72%,65 - 74岁女性的几率是其两倍。然而,2008年和2010年各年龄组之间在推荐方面没有差异。2009年,产科医生和妇科医生并未改变其推荐行为,而其他所有专科医生在2009年都减少了对40 - 49岁女性的推荐。与乳腺钼靶检查推荐相关的其他特征包括某些患者合并症、医生专科和初级保健医生身份、诊所的健康维护组织状况以及某些就诊特征。本研究表明USPSTF筛查指南的变化对乳腺钼靶检查推荐产生了暂时影响。然而,鉴于不同指南的推荐相互矛盾,医生倾向于采用更严格的指南,并未永久性减少对40 - 49岁女性的乳腺钼靶检查推荐。